SMT201400145B - Metodo per la rivelazione di anticorpi aBeta-specifici in un campione biologico - Google Patents

Metodo per la rivelazione di anticorpi aBeta-specifici in un campione biologico

Info

Publication number
SMT201400145B
SMT201400145B SM201400145T SM201400145T SMT201400145B SM T201400145 B SMT201400145 B SM T201400145B SM 201400145 T SM201400145 T SM 201400145T SM 201400145 T SM201400145 T SM 201400145T SM T201400145 B SMT201400145 B SM T201400145B
Authority
SM
San Marino
Prior art keywords
beta
detection
biological sample
specific antibodies
antibodies
Prior art date
Application number
SM201400145T
Other languages
English (en)
Italian (it)
Inventor
Gunther Staffler
Andreas Mairhofer
Achim Schneeberger
Martina Lutterova
Walter Schmidt
Frank Mattner
Original Assignee
Affiris Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Affiris Ag filed Critical Affiris Ag
Publication of SMT201400145B publication Critical patent/SMT201400145B/xx

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896Neurological disorders, e.g. Alzheimer's disease
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701Details
    • G01N2333/4709Amyloid plaque core protein
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/28Neurological disorders
    • G01N2800/2814Dementia; Cognitive disorders
    • G01N2800/2821Alzheimer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Sampling And Sample Adjustment (AREA)
SM201400145T 2011-10-04 2014-10-09 Metodo per la rivelazione di anticorpi aBeta-specifici in un campione biologico SMT201400145B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP11183842.1A EP2579042B1 (en) 2011-10-04 2011-10-04 Method for detecting Aß-specific antibodies in a biological sample

Publications (1)

Publication Number Publication Date
SMT201400145B true SMT201400145B (it) 2014-11-10

Family

ID=46888451

Family Applications (1)

Application Number Title Priority Date Filing Date
SM201400145T SMT201400145B (it) 2011-10-04 2014-10-09 Metodo per la rivelazione di anticorpi aBeta-specifici in un campione biologico

Country Status (24)

Country Link
US (2) US9625459B2 (el)
EP (3) EP2579042B1 (el)
JP (2) JP6162127B2 (el)
KR (2) KR20140069346A (el)
CN (2) CN103842825B (el)
AR (1) AR088108A1 (el)
AU (2) AU2012320766B2 (el)
BR (2) BR112014008088A2 (el)
CA (2) CA2850843A1 (el)
CY (1) CY1115624T1 (el)
DK (2) DK2579042T3 (el)
ES (2) ES2496341T3 (el)
HK (1) HK1178601A1 (el)
HR (1) HRP20140937T1 (el)
IL (2) IL231057A0 (el)
MX (2) MX2014003983A (el)
PL (2) PL2579042T3 (el)
PT (1) PT2579042E (el)
RS (1) RS53496B1 (el)
RU (2) RU2014117671A (el)
SG (2) SG11201400229XA (el)
SI (1) SI2579042T1 (el)
SM (1) SMT201400145B (el)
WO (2) WO2013050249A1 (el)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2787349A1 (en) 2013-04-03 2014-10-08 Affiris AG Method for detecting proteinopathy-specific antibodies in a biological sample
EP2787347A1 (en) * 2013-04-03 2014-10-08 Affiris AG Method for detecting Aß-specific antibodies in a biological sample
WO2015165961A1 (en) 2014-04-29 2015-11-05 Affiris Ag Treatment and prevention of alzheimer's disease (ad)
KR101658620B1 (ko) * 2014-12-02 2016-09-23 주식회사 피플바이오 응집형-형성 폴리펩타이드의 응집형을 검출하는 방법
KR20170108203A (ko) * 2016-03-16 2017-09-27 주식회사 피플바이오 응집형-형성 폴리펩타이드의 응집형을 검출하는 방법
KR101871895B1 (ko) * 2016-04-20 2018-06-28 한국과학기술연구원 응집 단백질의 고감도 광 산화 증폭 면역 분석을 통한 체액기반의 퇴행성 신경질환 진단 방법
EP3242134A1 (en) * 2016-05-04 2017-11-08 Euroimmun Medizinische Labordiagnostika AG Assay for the diagnosis of a neurological disease
KR101989383B1 (ko) * 2017-04-04 2019-06-14 조선대학교산학협력단 알츠하이머성 치매의 조기진단을 위한 펩타이드 프로브
KR102108171B1 (ko) * 2018-08-27 2020-05-08 광주과학기술원 알츠하이머성 치매 진단용 펩타이드 바이오마커
WO2020045962A1 (ko) * 2018-08-27 2020-03-05 광주과학기술원 알츠하이머성 치매 진단용 펩타이드 바이오마커
CN113075398A (zh) * 2021-03-23 2021-07-06 中国医学科学院输血研究所 一种血浆中特异性IgG抗体的定量测定方法
CN113063949A (zh) * 2021-03-23 2021-07-02 中国医学科学院输血研究所 一种血浆中特异性IgM抗体的定量测定方法

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5262332A (en) 1989-04-05 1993-11-16 Brigham And Women's Hospital Diagnostic method for Alzheimer's disease: examination of non-neural tissue
AU8083094A (en) 1994-10-19 1996-05-15 General Hospital Corporation, The A diagnostic assay for alzheimer's disease: assessment of abeta abnormalities
US7427392B1 (en) 1994-11-14 2008-09-23 Elan Pharmaceuticals, Inc. Methods for aiding in the diagnosis of alzheimer's disease by measuring amyloid-β peptide (x-≧41) and tau
TWI239847B (en) 1997-12-02 2005-09-21 Elan Pharm Inc N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease
UA81216C2 (en) 1999-06-01 2007-12-25 Prevention and treatment of amyloid disease
MXPA02001911A (es) * 1999-08-24 2003-07-21 Medarex Inc Anticuerpos ctla-4 humanos y sus usos.
AT413945B (de) 2003-01-14 2006-07-15 Mattner Frank Dr Impfstoff für die alzheimer-krankheit
KR100595494B1 (ko) 2003-02-24 2006-07-03 (주) 디지탈바이오텍 혈액 내 베타-아밀로이드 항체 농도를 이용한 알츠하이머병 진단키트
AT413336B (de) 2003-09-12 2006-02-15 Mattner Frank Dr Apherese-vorrichtung
AT500483B1 (de) 2004-07-13 2006-01-15 Mattner Frank Dr Set zur vorbeugung oder behandlung der alzheimer'schen erkrankung
AT413946B (de) 2004-07-13 2006-07-15 Mattner Frank Dr Impfstoff gegen die alzheimer-krankheit
DE102005006217B4 (de) * 2005-02-07 2007-08-16 Universitätsklinikum Hamburg-Eppendorf Diagnose von allergischen Erkrankungen und/oder atopischen Erkrankungen durch Nachweis von Autoantikörpern gegen CD28 in humanem Serum
TW200700432A (en) * 2005-03-05 2007-01-01 Abbott Gmbh & Co Kg Screening method, process for purifying of non-diffusible a β oligomers, selective antibodies against said non-diffusible a β oligomers and a process for manufacturing of said antibodies
TW200726774A (en) 2005-06-30 2007-07-16 Merck & Co Inc Composition and method for producing stable amyloid beta oligomers
CA2614473C (en) 2005-07-08 2016-05-03 Martek Biosciences Corporation Polyunsaturated fatty acids for treatment of dementia and pre-dementia-related conditions
RU2551782C2 (ru) * 2005-12-12 2015-05-27 Ац Иммуне Са Специфические в отношении амилоида бета (а бета) 1-42 моноклональные антитела, обладающие терапевтическими свойствами
US7939075B2 (en) * 2007-01-11 2011-05-10 Philipps-Universitaet Marburg Human monoclonal anti-amyloid-beta antibodies
WO2009051599A1 (en) * 2007-10-19 2009-04-23 The Regents Of The University Of California Use of biomarkers of alzheimer's disease for diagnostic tests and drug screening
US7771957B2 (en) * 2007-10-19 2010-08-10 The Regents Of The University Of California Method for diagnosing alzheimer's disease
AT506535B1 (de) 2008-02-22 2010-04-15 Affiris Forschungs & Entwicklungs Gmbh Vaccine enthaltend alpha-synuclein-mimotope auf basis von peptiden
AT506819B1 (de) 2008-06-12 2011-06-15 Affiris Forschungs Und Entwicklungs Gmbh Vakzin zur behandlung von alzheimer-krankheit
US20110092436A1 (en) 2008-06-12 2011-04-21 Affiris Ag Compounds for treating symptoms associated with parkinson's disease
AT506820B1 (de) 2008-06-12 2011-07-15 Affiris Forschungs Und Entwicklungs Gmbh Vakzine gegen alzheimer-krankheit
WO2010099199A1 (en) * 2009-02-24 2010-09-02 Gibbons Winton G Detection of complexes of tau and amyloid
WO2010128139A1 (en) 2009-05-08 2010-11-11 Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts, Universitätsmedizin Biomarkers and methods for diagnosing alzheimer's disease and/ or mild cognitive impairment
AT508638B1 (de) 2009-08-21 2011-08-15 Affiris Ag Verwendung von peptiden und polypeptiden zur behandlung und/oder prävention von synukleinopathien
JP2013521233A (ja) 2010-02-25 2013-06-10 ヤンセン アルツハイマー イミュノセラピー Aβを標的とする免疫療法のPETモニタリング

Also Published As

Publication number Publication date
AU2012320767A1 (en) 2014-03-13
US20140234877A1 (en) 2014-08-21
IL231057A0 (en) 2014-03-31
PL2579042T3 (pl) 2014-12-31
AU2012320766B2 (en) 2017-09-21
JP6162127B2 (ja) 2017-07-12
MX2014003984A (es) 2014-05-07
HK1178601A1 (en) 2013-09-13
SI2579042T1 (sl) 2014-09-30
WO2013050249A1 (en) 2013-04-11
AU2012320766A1 (en) 2014-03-13
SG11201400223SA (en) 2014-05-29
MX2014003983A (es) 2014-05-07
EP2579042B1 (en) 2014-07-09
CN103842825A (zh) 2014-06-04
CY1115624T1 (el) 2017-01-04
CA2850840A1 (en) 2013-04-11
AR088108A1 (es) 2014-05-07
RS53496B1 (en) 2015-02-27
CA2850843A1 (en) 2013-04-11
WO2013050248A1 (en) 2013-04-11
ES2692185T3 (es) 2018-11-30
DK2764367T3 (en) 2018-10-29
EP2764368A1 (en) 2014-08-13
CN103842825B (zh) 2016-04-20
SG11201400229XA (en) 2014-05-29
RU2014117677A (ru) 2015-11-10
BR112014008089A2 (pt) 2017-04-18
HRP20140937T1 (hr) 2014-12-05
PT2579042E (pt) 2014-09-09
RU2014117671A (ru) 2015-11-10
EP2764367B1 (en) 2018-07-25
KR20140073568A (ko) 2014-06-16
KR20140069346A (ko) 2014-06-09
PL2764367T3 (pl) 2019-04-30
BR112014008088A2 (pt) 2017-04-18
EP2764367A1 (en) 2014-08-13
US9625459B2 (en) 2017-04-18
CN103842824A (zh) 2014-06-04
ES2496341T3 (es) 2014-09-18
JP2014529087A (ja) 2014-10-30
US20140242727A1 (en) 2014-08-28
IL231620A0 (en) 2014-05-28
JP2014529088A (ja) 2014-10-30
DK2579042T3 (da) 2014-07-21
EP2579042A1 (en) 2013-04-10

Similar Documents

Publication Publication Date Title
SMT201400145B (it) Metodo per la rivelazione di anticorpi aBeta-specifici in un campione biologico
EP2755019A4 (en) METHOD OF DETECTING BIOLOGICAL SUBSTANCE
GB2485635B (en) Method for determining the presence or absence of different aneuploidies in a sample
EP3425063C0 (en) PROCEDURE FOR DETECTING ANALYTES
BR112013032816A2 (pt) método para a análise de espécimes biológicos através de imagem espectral
HK1201577A1 (en) Point-of care immunoassay for quantitative small analyte detection
SG11201401919TA (en) Optical systems and methods for biological analysis
ITRM20120383A1 (it) Metodo e kit per la rivelazione di anticorpi.
DK3370055T3 (da) Frem- og tilbagegående mikrotomdrivsystem
BR112014007789A2 (pt) sistemas e métodos para análise biológica
EP2663857A4 (en) METHOD OF DETECTION OF PROTEINS
FR2989465B1 (fr) Procede de determination de parametres geomecaniques d'un echantillon de roche
EP2613138A4 (en) PROCESS FOR DETECTION OF BIOLOGICAL SUBSTANCES
BR112014011900A2 (pt) um método de purificação de anticorpo
EP2833144A4 (en) METHOD OF DETECTING BIOLOGICAL SUBSTANCE
DK2732260T3 (da) Prøveopsamlingskit
EP2729784A4 (en) Measuring cell for liquid analysis system
BR112013019162A2 (pt) método de análise e dispositivo de leitura de microarranjo
BR112013023315A2 (pt) recipiente de amostragem para coleta de fluidos
HK1201074A1 (en) Method for determining an analyte concentration
EP2708880A4 (en) DEVICE FOR MEASURING A BIOLOGICAL SAMPLE AND METHOD OF MEASURING A BIOLOGICAL SAMPLE USING THE SAME
PL2780464T3 (pl) Sposób wykrywania w próbce obecności bakterii wytwarzających ß-laktamazy o szerokim spektrum działania
SG11201401345RA (en) Methods of detecting the presence of microorganisms in a sample
SG11201401911XA (en) Systems and methods for biological analysis
EP2740804A4 (en) PROCESS FOR NUCLEIC ACID ANALYSIS